BURLINGAME, CA, UNITED STATES, February 16, 2026 /EINPresswire.com/ -- The Global Business Landscape is being reshaped by rapid innovation, rising investment and ...

As interest in CAR T cells and immune-based oncology therapies increases, efficient phenotyping of cell therapy products ...

From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN ...

Technological advances, clinical demand, and comprehensive tumor cell analysis are driving growth in the circulating tumor cell detection market, offering opportunities in diagnostics and clinical ...

Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically meaningful 3D models—faster, more consistently, and with full traceability. Yet ...

A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s ...

Dr. William Chen discusses NAMs, AI, and the future of risk assessment for cell-based foods With cultivated meat emerging as one of the most promising innovations in alternative proteins, regulators ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

BioLife Solutions has executed a successful turnaround by refocusing on core products and divesting non-core assets. Read ...